Skip to main content
. 2017 Jul 7;8:783. doi: 10.3389/fimmu.2017.00783

Figure 1.

Figure 1

Determination of myeloid-derived suppressor cells number and percentage in whole blood of healthy, amnestic mild cognitive impairment (aMCI), and mild AD (mAD) subjects. (A) Number of CD33+HLA-DR cells in whole blood. (B) Percentage of CD33+HLA-DR cells in whole blood. (C) Number of CD33+HLA-DRCD11b+CD15+ cells in whole blood. (D) Percentage of CD33+HLA-DRCD11b+CD15+ cells in whole blood. Each group was composed of five independent subjects with determinations made in triplicate. Data are shown as the mean ± SEM. The asterisks (*) correspond to p < 0.05.